The evidence of VEGF-A involvement in gastric cancer metastases derives from the demonstration that increased VEGF-A levels in cancer tissues correlate with higher expression of collapsin response mediator protein family 4 (CRMP4), a protein involved in the metastatic process [207]. This evidence concerns the gene VEGFA and gastric cancer.